1
|
Immunoinformatics guided design of a next generation epitope-based vaccine against Kaposi Sarcoma. INFORMATICS IN MEDICINE UNLOCKED 2022. [DOI: 10.1016/j.imu.2022.100986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
2
|
Blaison F, Galtier J, Parrens M, Viallard JF, Boutboul D. [HHV-8 Related immunological and hematological diseases]. Rev Med Interne 2021; 43:301-311. [PMID: 34895767 DOI: 10.1016/j.revmed.2021.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2021] [Revised: 09/21/2021] [Accepted: 10/09/2021] [Indexed: 10/19/2022]
Abstract
HHV-8 is an oncogenic Gammaherpesvirinae discovered in 1994 during the HIV pandemic. It is the causative agent of Kaposi's sarcoma, and is also associated with the occurrence of several aggressive B lymphoproliferative disorders. Most of them occur in an immunosuppression setting, usually due to HIV infection. Multicentric HHV8-associated Castleman's disease and KSHV Inflammatory Cytokine Syndrome (KICS) are primarily reactive entities with prominent systemic features. They illustrate the cytokinic storm induced by HHV-8 in its cell host. On the other hand, HHV-8 can drive proliferation and lymphomagenesis of its plasmablastic cell host, and is associated with a risk to develop aggressive lymphomas with plasmacytic differenciation. Primary effusion lymphoma usually localizes in body cavities and may affect other extra-nodal sites ; its prognostic is poor. Diffuse large B-cell lymphoma HHV-8, NOS affect more commonly nodes and blood and evolve from infected cell of HHV-8 associated Castleman disease. On the contrary, germinotropic lymphoproliferative disorders presents mainly as localized adenopathy with indolent course, and show polyclonality. Histology plays a key role in distinguishing these different entities and need expert reviewing, especially since they may be associated with each other. Besides lymphoproliferative disorders, HHV8 is associated with various hematological manifestations. The aim of this review is to provide an update on the presentation, diagnosis, and management of immunologic and hematologic complications associated with HHV-8.
Collapse
Affiliation(s)
- F Blaison
- Service de médecine interne et maladies infectieuses, centre de compétence de la maladie de Castleman, hôpital Haut Lévêque CHU de Bordeaux, 33600 Pessac, France
| | - J Galtier
- Service d'hématologie et de thérapie cellulaire, hôpital Haut Lévêque CHU de Bordeaux, 33600 Pessac, France.
| | - M Parrens
- Service d'anatomie et cytologie pathologique, hôpital Haut Lévêque, CHU de Bordeaux, 33600 Pessac, France; Inserm U1053, université de Bordeaux, 146, rue Léo Saignat, 33076 Bordeaux, France
| | - J-F Viallard
- Service de médecine interne et maladies infectieuses, centre de compétence de la maladie de Castleman, hôpital Haut Lévêque CHU de Bordeaux, 33600 Pessac, France
| | - D Boutboul
- Service d'immunopathologie, centre de référence national de la maladie de Castleman, hôpital Saint-Louis, université de Paris, Paris, France
| |
Collapse
|
3
|
Harzallah A, Ounissi M, Hajji M, Chargui S, Hedri H, Abderrahim E, Ben Hamida F, Bacha M, Ben Abdallah T. [Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma]. Nephrol Ther 2021; 17:132-136. [PMID: 33563572 DOI: 10.1016/j.nephro.2020.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Revised: 08/23/2020] [Accepted: 10/11/2020] [Indexed: 10/22/2022]
Abstract
We report the observation of a patient who presented with post-transplant Kaposi's sarcoma after a delay of eight months with a dual cutaneous and palatal localisation. The reduction in immunosuppressive treatment and the introduction of Rapamune® allowed good clinical progress initially with regression of the skin lesions. He subsequently presented later a skin relapse with visceral localisation. Chemotherapy was conducted based on weekly paclitaxel infusions allowing partial remission and maintenance of renal graft function with good clinical tolerance.
Collapse
Affiliation(s)
- Amel Harzallah
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie.
| | - Mondher Ounissi
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Meriem Hajji
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Soumaya Chargui
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Hafedh Hedri
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Ezzeddine Abderrahim
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Fathi Ben Hamida
- Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie; Laboratoire de pathologie rénale LR00SP01, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Mongi Bacha
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| | - Taieb Ben Abdallah
- Faculté de médecine de Tunis, université de Tunis El Manar, 1007 Tunis, Tunisie; Service de médecine A, hôpital Charles-Nicolle, 1006 Tunis, Tunisie
| |
Collapse
|
4
|
Abstract
Donor-derived infections are defined as any infection present in the donor that is transmitted to 1 or more recipients. Donor-derived infections can be categorized into 2 groups: "expected" and "unexpected" infections. Expected transmissions occur when the donor is known to have an infection, such as positive serology for cytomegalovirus, Epstein Barr virus, or hepatitis B core antibody, at the time of donation. Unexpected transmissions occur when a donor has no known infection before donation, but 1 or more transplant recipients develop an infection derived from the common donor. Unexpected infections are estimated to occur in far less than 1% of solid organ transplant recipients. We will review the epidemiology, risk factors, and approaches to prevention and management of donor-derived viral infectious disease transmission in liver transplantation.
Collapse
|
5
|
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation. Transplantation 2016; 100:134-40. [PMID: 26120765 DOI: 10.1097/tp.0000000000000801] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Kaposi sarcoma is the most common human herpesvirus 8 (HHV-8)-related disease described after solid organ transplantation. Multicentric Castleman disease and hemophagocytic syndrome are other potential HHV-8-induced entities but are less frequently reported. We describe the case of a liver transplant recipient who presented with an acute febrile illness 1 year after transplantation with a rapidly fatal outcome. Autopsy revealed 3 distinct HHV-8-related entities: Kaposi sarcoma, HHV-8-associated multicentric Castleman disease with microlymphomas and a severe hemophagocytic syndrome. Retrospective serologic tests suggested that HHV-8 was likely transmitted by the seropositive donor at the time of transplantation. To our knowledge, this is the first case of copresentation of 3 clinical presentations of HHV-8-mediated human disease in the post-transplant setting. Considering the absence of systematic screening of organ donors/recipients for HHV-8 infection, HHV-8-related illness should be suspected in transplant recipients who present with acute febrile illness, systemic symptoms, lymphadenopathies, and/or multiorgan failure to rapidly document the diagnosis and provide timely an adequate treatment.
Collapse
|
6
|
Bellazreg F, Knani L, Ben Abdelkarim S, Hattab Z, Hachfi W, Ben Hadj Hamida F, Letaief A. [HIV-associated conjunctivo-palpebral Kaposi's sarcoma: A case report]. J Fr Ophtalmol 2016; 39:e93-5. [PMID: 26947324 DOI: 10.1016/j.jfo.2014.11.030] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Accepted: 11/28/2014] [Indexed: 11/18/2022]
Affiliation(s)
- F Bellazreg
- Service de maladies infectieuses, CHU Farhat Hached, 4000 Sousse, Tunisie.
| | - L Knani
- Service d'ophtalmologie, CHU Farhat Hached, 4000 Sousse, Tunisie
| | - S Ben Abdelkarim
- Laboratoire d'anatomie et de cytologie pathologiques, CHU Farhat Hached, 4000 Sousse, Tunisie
| | - Z Hattab
- Service de maladies infectieuses, CHU Farhat Hached, 4000 Sousse, Tunisie
| | - W Hachfi
- Service de maladies infectieuses, CHU Farhat Hached, 4000 Sousse, Tunisie
| | | | - A Letaief
- Service de maladies infectieuses, CHU Farhat Hached, 4000 Sousse, Tunisie
| |
Collapse
|
7
|
Sebbar A, Zaghba N, Benjelloun H, Bakhatar A, Yassine N. [Kaposi sarcoma in bronchopulmonary localization revealing HIV infection]. Pan Afr Med J 2015; 22:279. [PMID: 26958142 PMCID: PMC4765336 DOI: 10.11604/pamj.2015.22.279.7476] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2015] [Accepted: 10/31/2015] [Indexed: 11/11/2022] Open
Abstract
La maladie de Kaposi (MK) associée au VIH, forme dite épidémique, a été décrite la 1ère fois en 1981 par Hymmes. C'est l'affection maligne la plus fréquente au cours du SIDA. La MK est à l'origine de 10% des atteintes pleuropulmonaires au cours de l'infection par le VIH et 40% des pneumopathies en cas de MK cutanéomuqueuse. Les localisations pulmonaires occupent la deuxième place des atteintes viscérales après la forme digestive. Le diagnostic repose sur des arguments épidémiologiques, cliniques, radiologiques, biologiques, endoscopiques et histologiques. Nous rapportons un cas de MK broncho-pulmonaire compliquant une infection VIH chez un patient présentant une maladie de Kaposi cutanée de découverte fortuite au cours de l'atteinte pulmonaire. Le diagnostic a été retenu après avoir éliminé les maladies opportunistes à tropisme pulmonaire. Le Kaposi pulmonaire constitue l'atteinte la plus grave de la MK-sida et la survie après le diagnostic est courte malgré les thérapeutiques agressives.
Collapse
Affiliation(s)
- Amal Sebbar
- Service des Maladies Respiratoires, CHU Ibn Rochd, Casablanca, Maroc
| | - Nahid Zaghba
- Service des Maladies Respiratoires, CHU Ibn Rochd, Casablanca, Maroc
| | - Hanane Benjelloun
- Service des Maladies Respiratoires, CHU Ibn Rochd, Casablanca, Maroc
| | | | - Najiba Yassine
- Service des Maladies Respiratoires, CHU Ibn Rochd, Casablanca, Maroc
| |
Collapse
|
8
|
Dochez V, Ducarme G. [Acute herpesviridae hepatitis during pregnancy: A review]. Presse Med 2015; 44:660-6. [PMID: 26033557 DOI: 10.1016/j.lpm.2015.04.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Revised: 04/16/2015] [Accepted: 04/21/2015] [Indexed: 02/07/2023] Open
Abstract
Viral hepatitis are well defined during pregnancy, including hepatitis A, B, C, D or E. In contrast, viral hepatitis called non-alphabetic, like viruses Herpesviridae family hepatitis [cytomegalovirus (CMV), varicella-zoster virus (VZV), Epstein-Barr virus (EBV) or herpes simplex virus (HSV)] are rarely described. The aim of this article is to make a focus on the care of these viral herpesviridae hepatitis during pregnancy. Herpes hepatitis is more common during pregnancy, with a neonatal risk at peripartum period. VZV infection can cause disease to the fetus, with possible vertical transmission, and induce congenital or neonatal varicella. While EBV infection during pregnancy seems benign, the CMV is a high risk of birth defects. The management of these patients therefore depends on the gestational age, but especially the type of virus involved. The diagnosis is therefore essential to adapt treatment and obstetrical care.
Collapse
Affiliation(s)
- Vincent Dochez
- Centre hospitalier départemental, service de gynécologie obstétrique, 85000 La Roche-sur-Yon, France
| | - Guillaume Ducarme
- Centre hospitalier départemental, service de gynécologie obstétrique, 85000 La Roche-sur-Yon, France.
| |
Collapse
|
9
|
Ahmadi Ghezeldasht S, Hassannia T, Rafatpanah H, Hekmat R, Valizadeh N, Ghayour Mobarhan M, Rezaee SA. Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran. Jundishapur J Microbiol 2015; 8:e14920. [PMID: 25834713 PMCID: PMC4377171 DOI: 10.5812/jjm.14920] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Revised: 12/14/2013] [Accepted: 07/06/2014] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Globally, almost 20% of cancers are related to infectious agents that can be prevented. Oncogenicity refers to viruses that may cause cancers, more importantly in immunocompromised subjects such as transplant and hemodialysis patients. Therefore, epidemiological studies are the first line for understanding the importance of these agents in public health, particularly, in mobile populations, tourism and pilgrimage regions. OBJECTIVES Oncogenic viral infections, such as hepatitis B virus (HBV), hepatitis C virus (HCV) and Epstein-barr virus (EBV) are the most common viral agents in immunocompromised patients. Furthermore, human T lymphocyte virus type I (HTLV-I), due to endemicity in Khorasan Razavi province located northeast of Iran as a pilgrimage region, and Kaposi's sarcoma associated herpes virus (KSHV), as an oncogenic herpesvirus in immunocompromised subjects have been investigated among the general population and those with end-stage renal diseases (ESRD). PATIENTS AND METHODS A cross-sectional study was carried out among 1227 randomly selected individuals; 25 donors and 195 patients with ESRD, including 60 kidney transplant recipients and 135 dialysis patients from the Khorasan Razavi province, Iran. Serological tests were carried out using commercial enzyme-immunoassay kits. To confirm positive serology tests, the extracted viral DNA or RNA was examined for the presence of KSHV, HTLV-I and HCV by conventional PCR. RESULTS The prevalence of KSHV infection in the general population was 1.71% (21/1227); 2.60% (10/384) males and 1.30% (11/843) females. In kidney transplants, viral infections occurred in 23.3% of subjects; including EBV, HTLV-I and HBV-HCV co-infection in 8.3%, 3.3% and 1.7%, respectively. In patients on hemodialysis, viral infections were present in 29.6% including EBV, HTLV-I and HBV-HCV co-infection in 2.2%, 5.9% and 16.3%, respectively. Seroprevalence of KSHV in patients with kidney transplants was 1.7% and in patients on dialysis was 3.0%. Furthermore, KSHV and HTLV-I genome was detected in 25% and 100% of seropositive subjects, respectively. CONCLUSIONS In conclusion, this study demonstrated that these tumor virus infections including HTLV-I, KSHV and particularly hepatitis viruses (HBV plus HCV) are prevalent in the general population and in patients on hemodialysis, which might be an important health concern in this region due to the mobile population.
Collapse
Affiliation(s)
- Sanaz Ahmadi Ghezeldasht
- Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
| | - Tahereh Hassannia
- Internal Medicine Department, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
| | - Houshang Rafatpanah
- Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
| | - Reza Hekmat
- Nephrology Department, Mashhad University of Medical Sciences, Mashhad, IR Iran
| | - Narges Valizadeh
- Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
| | - Majid Ghayour Mobarhan
- Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
| | - Seyed Abdolrahim Rezaee
- Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
- Inflammation and Inflammatory Diseases Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, IR Iran
- Corresponding author: Seyed Abdolrahim Rezaee, Inflammation and Inflammatory Diseases Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, IR Iran. Tel: +98-5138436626, E-mail:
| |
Collapse
|
10
|
Brunet-Possenti F, Pages C, Rouzier R, Dupin N, Bagot M, Lebbé C. Kaposi's Sarcoma and Pregnancy: Case Report and Literature Review. Dermatology 2013; 226:311-4. [DOI: 10.1159/000349987] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Accepted: 02/12/2013] [Indexed: 11/19/2022] Open
|
11
|
Affiliation(s)
- Celeste Lebbé
- Department of Dermatology, APHP Hospital Saint Louis, Paris, Inserm U 716, France
| | | |
Collapse
|
12
|
|
13
|
Prévalence des manifestations dermatologiques chez les malades infectés par le VIH au Sénégal et association avec le degré d’immunodépression. Ann Dermatol Venereol 2008; 135:187-93. [DOI: 10.1016/j.annder.2007.11.022] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2007] [Accepted: 11/23/2007] [Indexed: 11/21/2022]
|
14
|
|
15
|
Hassan G, Khalaf H, Mourad W. Dermatologic complications after liver transplantation: a single-center experience. Transplant Proc 2007; 39:1190-4. [PMID: 17524929 DOI: 10.1016/j.transproceed.2007.04.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To report our experience with dermatological complications after both deceased donor liver transplantation (DDLT) and living-donor liver transplantation (LDLT). PATIENTS AND METHODS Between April 2001 and November 2006, a total of 116 liver transplantation (LT) procedures were performed (73 DDLTs and 43 LDLTs) in 112 patients (4 re-transplants). Posttransplant dermatological problems were recorded. RESULTS Among 112 OLT recipients, 14 patients (12.5%) experienced dermatologic problems: epidermolysis bullosa acquisita in one patient, which was self-limiting; graft-versus-host-disease in one patient treated with high-dose steroids; Kaposi sarcoma in one patient treated with surgical excision and conversion to sirolimus-based immunosuppression; drug-induced cutaneous vasculitis with deep thigh ulcer formation treated by drug discontinuation and surgical excision of the ulcer; herpes zoster in one patient treated with intravenous antiviral therapy; herpes simplex in two patients treated with local antiviral cream; cyclosporine-induced gingival hyperplasia treated with conversion to FK506; cyclosporine-induced hypertrichosis treated with conversion to FK506; steroid-induced skin hyperpigmentation in one patient treated with steroid withdrawal; hypomagnesemia-induced hair loss treated with daily oral magnesium supplement; pressure-induced alopecia areata in two patients that was self-limiting; and finally, one patient with a pressure-induced heel ulcer that was treated conservatively. In 8 of 14 patients (57%) who suffered from dermatologic problems, the complication was primarily related to immunosuppressive drugs. CONCLUSIONS In our experience, dermatologic complications following LT are not uncommon and usually related to immunosuppressive therapy. Most complications could be prevented by optimizing immunosuppression. The majority of complications were easily managed by simple adjustment of immunosuppression.
Collapse
Affiliation(s)
- G Hassan
- Department of Liver Transplantation and Hepatobiliary-Pancreatic Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | | | | |
Collapse
|